文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

NAFLD in Lean Asians.

作者信息

Eslam Mohammed, Chen Fei, George Jacob

机构信息

Storr Liver Centre Westmead Institute for Medical Research Westmead Hospital and University of Sydney Westmead New South Wales Australia.

出版信息

Clin Liver Dis (Hoboken). 2021 Jan 13;16(6):240-243. doi: 10.1002/cld.930. eCollection 2020 Dec.

DOI:10.1002/cld.930
PMID:33489095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7805295/
Abstract
摘要

相似文献

[1]
NAFLD in Lean Asians.

Clin Liver Dis (Hoboken). 2021-1-13

[2]
Lean NAFLD: An Underrecognized Outlier.

Curr Hepatol Rep. 2016-6

[3]
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.

J Clin Transl Hepatol. 2017-9-28

[4]
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Hepatol Commun. 2017-11-30

[5]
Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.

Indian J Gastroenterol. 2020-2

[6]
Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.

J Gastroenterol Hepatol. 2018-7-16

[7]
Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.

Aliment Pharmacol Ther. 2017-10-30

[8]
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

Clin Gastroenterol Hepatol. 2017-5-26

[9]
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.

Aliment Pharmacol Ther. 2017-7

[10]
Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.

Arch Iran Med. 2017-4

引用本文的文献

[1]
The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study.

Sci Rep. 2025-7-24

[2]
Effect of lean status on the mortality of patients with non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.

Pak J Med Sci. 2025-6

[3]
Differential risk factors of fibrosis between lean and obese MAFLD.

Clin Exp Med. 2025-6-18

[4]
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena.

Liver Res. 2022-5-19

[5]
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic.

World J Hepatol. 2024-4-27

[6]
Gut microbiota in MAFLD: therapeutic and diagnostic implications.

Ther Adv Endocrinol Metab. 2024-4-15

[7]
Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.

Eur J Med Res. 2024-3-20

[8]
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome.

Diabetes Metab J. 2024-3

[9]
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside.

J Clin Med. 2024-1-3

[10]
NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance.

J Clin Exp Hepatol. 2024

本文引用的文献

[1]
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.

Hepatology. 2020-4

[2]
Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.

Eur J Endocrinol. 2019-8

[3]
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

J Hepatol. 2018-8-22

[4]
Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non-Alcoholic Steatohepatitis.

Basic Clin Pharmacol Toxicol. 2018-7-30

[5]
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.

N Engl J Med. 2018-6-21

[6]
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Hepatol Commun. 2017-11-30

[7]
Genetics and epigenetics of NAFLD and NASH: Clinical impact.

J Hepatol. 2017-11-6

[8]
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Nat Rev Gastroenterol Hepatol. 2017-9-20

[9]
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

Hepatology. 2017-11-6

[10]
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.

Am J Gastroenterol. 2017-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索